Clinical Trial Update: Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years [Phase 3]

View source ↗

Summary

Phase 3 long-term follow-up study comparing two formulations of a combined hepatitis A/B vaccine in adolescents (ages 12-15); results covering years 6 through 1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Hepatitis B

Drugs mentioned

• Twinrix (Hepatitis A and B vaccine, combined)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Hepatitis A | Phase 3 | Status: COMPLETED | Results posted: 2009-08-14